{
  "schemaVersion": 2,
  "eyebrow": "Emergency Medicine",
  "title": "Hyperkalemia Emergency Treatment",
  "summary": "Treat hyperkalemia as an electrical emergency when potassium exceeds 6.0 mmol/L or ECG toxicity is present: monitor, stabilize myocardium with IV calcium, shift potassium intracellularly, remove total-body potassium, and reassess for rebound or dialysis need.",
  "seoDescription": "Point-of-care emergency treatment of hyperkalemia: ECG monitoring, IV calcium, insulin-dextrose, albuterol, bicarbonate, potassium removal, and dialysis escalation.",
  "clinicalQuestion": "How should physicians stabilize, temporize, definitively remove potassium, and monitor adults with acute hyperkalemia?",
  "specialty": "Emergency Medicine and Nephrology",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "acute hyperkalemia",
    "hyperkalemia emergency treatment",
    "IV calcium",
    "insulin dextrose hyperkalemia",
    "albuterol hyperkalemia",
    "urgent dialysis",
    "ECG changes hyperkalemia"
  ],
  "keyTakeaways": [
    "Obtain a 12-lead ECG and institute cardiac monitoring when potassium is greater than 6.0 mmol/L; ECG changes or severe potassium elevation warrant immediate treatment rather than waiting for repeat confirmation. [6][7][8]",
    "Give IV calcium immediately for hyperkalemia-associated ECG abnormalities; calcium stabilizes cardiac excitability but does not lower serum potassium. [8][12]",
    "For intracellular redistribution, IV regular insulin 5 units with 25 g glucose and nebulized albuterol 10 mg are supported acute options and may have additive potassium-lowering effects. [12]",
    "Check glucose serially after insulin, especially in kidney failure; hypoglycemia after insulin-dextrose has been reported despite concomitant dextrose and monitoring for at least 3 hours is supported in ESRD. [13][14]",
    "Definitive potassium removal requires renal excretion, gastrointestinal binding, or hemodialysis; hemodialysis is the preferred and most effective urgent elimination method when indicated. [11][12][18]"
  ],
  "sections": [
    {
      "id": "triage-and-confirmation",
      "eyebrow": "First Minutes",
      "heading": "Identify patients requiring monitored emergency treatment",
      "intro": "Use potassium concentration, electrical toxicity, and clinical context to determine urgency.",
      "paragraphs": [
        "Place patients with potassium greater than 6.0 mmol/L on continuous cardiac monitoring and obtain a 12-lead ECG. Refer patients with potassium greater than 6.0 mmol/L or any hyperkalemia-associated ECG change to an emergency setting capable of immediate monitored treatment. [6][7][8]",
        "Do not use a normal ECG to exclude clinically consequential hyperkalemia. Reported manifestations include peaked T waves, PR prolongation, P-wave flattening, QRS widening, and ventricular fibrillation, but ECG changes need not progress sequentially and ventricular fibrillation can occur without preceding classic findings. [8]",
        "Repeat potassium promptly when hemolysis, collection artifact, or pseudohyperkalemia is plausible, but do not allow confirmation to delay therapy in a patient with potassium greater than 6.0 mmol/L plus ECG toxicity or clinical instability. Obtain rapid biochemical confirmation and assess for acute kidney injury, chronic kidney disease, end-stage kidney disease, metabolic acidosis, diabetes, heart failure, and medication contributors. [7][8][9]"
      ],
      "bullets": [
        "Treat the ECG, not a potassium value alone: new conduction delay, bradyarrhythmia, QRS widening, or ventricular dysrhythmia requires immediate membrane stabilization. [8][12]",
        "Review ACE inhibitor, ARB, potassium-sparing diuretic, and other potassium-raising exposures while assessing renal function and ongoing potassium burden. [9]",
        "If emergent hyperkalemia prompts temporary interruption of a renin-angiotensin system inhibitor, plan reassessment and reinitiation after resolution when the original indication remains present. [5]"
      ],
      "subsections": [],
      "table": {
        "caption": "Initial emergency actions are driven by potassium greater than 6.0 mmol/L, ECG findings, and ability to remove potassium. [6][7][8][12]",
        "columns": [
          "Finding",
          "Immediate action",
          "What it changes"
        ],
        "rows": [
          [
            "Potassium >6.0 mmol/L",
            "Continuous cardiac monitoring and 12-lead ECG. [6][8]",
            "Identifies electrical toxicity and need for immediate stabilization. [8]"
          ],
          [
            "ECG changes attributable to hyperkalemia",
            "Give IV calcium immediately, then initiate potassium redistribution and removal. [8][12]",
            "Calcium addresses imminent cardiac conduction risk but does not eliminate potassium. [8]"
          ],
          [
            "Hemolyzed or discordant potassium result without instability",
            "Repeat biochemical potassium measurement while evaluating pseudohyperkalemia. [7][8]",
            "Avoids treating a spurious result; do not delay treatment when ECG toxicity is present. [7][8]"
          ],
          [
            "Severely impaired kidney function or absent effective excretion",
            "Arrange hemodialysis early while temporizing measures are administered. [10][11][12]",
            "Dialysis provides definitive, most effective potassium elimination. [11][12]"
          ]
        ]
      }
    },
    {
      "id": "cardiac-stabilization",
      "eyebrow": "Electrical Toxicity",
      "heading": "Use IV calcium for hyperkalemic ECG abnormalities",
      "intro": "Calcium is the first medication when hyperkalemia is producing electrical instability.",
      "paragraphs": [
        "Administer IV calcium immediately when hyperkalemia-associated ECG changes are present. The KDIGO emergency algorithm lists either calcium gluconate 1 g IV, repeatable up to three 1-g doses using 10 mL of 10% solution per dose, or calcium chloride 1 g IV using 10 mL of 10% solution. [8][12]",
        "Select calcium as myocardial protection while concurrently initiating therapies that shift and remove potassium. It is not a potassium-lowering therapy; failure to pair calcium with redistribution and elimination permits recurrent electrical toxicity as serum potassium remains elevated. [8][12]"
      ],
      "bullets": [
        "Use calcium gluconate 1 g IV as a listed emergency regimen; the referenced algorithm permits up to three sequential 1-g doses. [12]",
        "Calcium chloride 1 g IV is an alternative listed in the same algorithm. [12]",
        "Continue ECG monitoring after calcium because potassium-associated conduction abnormalities may recur until potassium is redistributed and definitively removed. [8][12]"
      ],
      "subsections": [],
      "table": {
        "caption": "IV calcium regimens for hyperkalemia-associated ECG toxicity. [12]",
        "columns": [
          "Agent",
          "Listed IV dose",
          "Clinical role"
        ],
        "rows": [
          [
            "Calcium gluconate",
            "1 g IV; algorithm lists up to 3 doses of 1 g, each as 10 mL of 10% solution. [12]",
            "Immediate myocardial membrane stabilization in ECG-toxic hyperkalemia. [8][12]"
          ],
          [
            "Calcium chloride",
            "1 g IV, 10 mL of 10% solution. [12]",
            "Alternative calcium preparation for immediate myocardial membrane stabilization. [12]"
          ]
        ]
      }
    },
    {
      "id": "intracellular-redistribution",
      "eyebrow": "Temporizing Therapy",
      "heading": "Shift potassium intracellularly while arranging elimination",
      "intro": "Redistribution buys time; it does not reduce total-body potassium.",
      "paragraphs": [
        "Use IV regular insulin with dextrose as a principal rapid intracellular-shift therapy. A KDIGO emergency regimen is regular insulin 5 units IV plus 25 g glucose IV; other guideline-referenced regimens use 5 to 10 units of IV insulin with 25 to 50 g dextrose. [12][14] A commonly used alternative is 10 units of regular insulin IV with 25 g dextrose. [13]",
        "Add nebulized albuterol 10 mg when further rapid redistribution is needed and no patient-specific concern precludes beta-agonist use. Insulin and albuterol may have additive effects, although albuterol is ineffective in some patients; expected adverse effects include tremor, palpitations, headache, and mild hyperglycemia. [11][12]",
        "Reserve IV sodium bicarbonate for patients with concomitant metabolic acidosis rather than routine use in normoacidic hyperkalemia. The KDIGO algorithm lists 50 mmol IV over 15 minutes; bicarbonate has little potassium-lowering effect without acidosis and is not indicated as routine acute therapy. [11][12][18]"
      ],
      "bullets": [
        "Check bedside glucose before IV insulin and serially afterward; kidney dysfunction increases concern for delayed hypoglycemia. [13][14]",
        "In ESRD, provide dextrose support and monitor glucose for at least 3 hours after insulin-based treatment. [13]",
        "Do not regard insulin, albuterol, or bicarbonate as definitive therapy; each acts by transcellular redistribution and must be followed by a potassium-removal plan. [18][20]"
      ],
      "subsections": [
        {
          "heading": "Prevent and detect insulin-associated hypoglycemia",
          "paragraphs": [
            "Hypoglycemia is a major treatment complication after insulin-dextrose, particularly in reduced kidney function. Published incidence estimates vary from 6.1% to 75%, and one ESRD study reported blood glucose below 55 mg/dL at 1 hour in 9 of 12 patients receiving 10 units of IV regular insulin with 25 g dextrose. [13][14]"
          ],
          "bullets": [
            "Use serial glucose measurements after insulin rather than a single post-treatment value. [8][13][14]",
            "Maintain at least 3 hours of glucose monitoring in ESRD after insulin treatment. [13]"
          ]
        }
      ],
      "table": {
        "caption": "Temporizing potassium-shift therapies and their key limitations. [11][12][13][14][18]",
        "columns": [
          "Therapy",
          "Supported regimen",
          "Selection and monitoring"
        ],
        "rows": [
          [
            "Regular insulin plus glucose",
            "Regular insulin 5 units IV plus glucose 25 g IV; guidelines cited elsewhere describe 5-10 units with 25-50 g dextrose. [12][14]",
            "Use for rapid redistribution; measure glucose serially because hypoglycemia is common, particularly with reduced kidney function. [13][14]"
          ],
          [
            "Nebulized albuterol",
            "10 mg nebulized. [12]",
            "Can be combined with insulin for additive effect; recognize occasional nonresponse and beta-agonist adverse effects. [11][12]"
          ],
          [
            "Sodium bicarbonate",
            "50 mmol IV over 15 minutes in the KDIGO algorithm. [12]",
            "Reserve for coexisting metabolic acidosis; it has limited effect without acidosis. [11][18]"
          ]
        ]
      }
    },
    {
      "id": "potassium-elimination",
      "eyebrow": "Definitive Therapy",
      "heading": "Remove potassium and escalate early to hemodialysis when needed",
      "intro": "A successful emergency plan includes a route for total-body potassium elimination.",
      "paragraphs": [
        "Hemodialysis is the preferred and most effective method of urgent potassium elimination. Arrange it early for severe hyperkalemia when kidney function is too poor for meaningful renal potassium excretion, when hyperkalemia persists despite medical management, or when recurrent elevation is expected while temporizing therapies wear off. [10][11][12]",
        "If the patient has sufficient kidney function, loop diuretics can support urinary potassium removal; their utility depends on preserved renal function. [10][18] Correct the precipitating process that is limiting potassium excretion or creating ongoing release, including acute kidney injury, chronic kidney disease, metabolic acidosis, and potassium-raising medication combinations. [9][18]",
        "Gastrointestinal binders may contribute to potassium elimination but should not replace immediate calcium, insulin-dextrose, albuterol, or dialysis planning in ECG-toxic hyperkalemia. The KDIGO algorithm lists sodium polystyrene sulfonate 15 to 60 g orally or rectally without sorbitol and sodium zirconium cyclosilicate 10 g orally three times daily; it states that patiromer is not advisable for emergency use because onset is approximately 7 hours. [12]"
      ],
      "bullets": [
        "Avoid sodium polystyrene sulfonate with sorbitol; the agent has been associated with rare gastrointestinal toxicity and long-term use is poorly tolerated. [12][18]",
        "Use binders as adjunctive elimination therapy only after determining whether dialysis is required. [11][12]",
        "When an ACE inhibitor or ARB was held for emergent hyperkalemia, reassess and restart after the adverse event resolves when clinically indicated rather than leaving the patient indefinitely without disease-modifying therapy. [5]"
      ],
      "subsections": [],
      "table": {
        "caption": "Potassium-elimination options after emergency stabilization. [10][11][12][18]",
        "columns": [
          "Method",
          "When to use",
          "Key limitation or instruction"
        ],
        "rows": [
          [
            "Hemodialysis",
            "Severe or persistent hyperkalemia with inadequate renal elimination or need for urgent definitive removal. [10][11][12]",
            "Most effective and preferred urgent elimination modality; arrange while medical temporizing therapy is underway. [11][12]"
          ],
          [
            "Loop diuretic",
            "Patient has reasonable kidney function and capacity for urinary potassium excretion. [10][18]",
            "Not a reliable sole strategy when renal function is severely impaired. [10]"
          ],
          [
            "Sodium polystyrene sulfonate",
            "Adjunctive gastrointestinal potassium removal; KDIGO algorithm lists 15-60 g orally or rectally. [12]",
            "Do not administer with sorbitol; gastrointestinal toxicity is a recognized concern. [12][18]"
          ],
          [
            "Sodium zirconium cyclosilicate",
            "Adjunctive gastrointestinal potassium removal; KDIGO algorithm lists 10 g orally three times daily. [12]",
            "Limited emergency-onset data and no head-to-head binder data in the cited algorithm. [12]"
          ],
          [
            "Patiromer",
            "More relevant to ongoing potassium management than immediate electrical emergencies. [18]",
            "Not advisable for emergency treatment in the KDIGO algorithm because onset is approximately 7 hours. [12]"
          ]
        ]
      }
    },
    {
      "id": "reassessment-and-disposition",
      "eyebrow": "After Initial Treatment",
      "heading": "Recheck potassium, glucose, ECG status, and definitive elimination",
      "intro": "Monitoring must detect recurrent electrical toxicity, treatment complications, and rebound hyperkalemia.",
      "paragraphs": [
        "Reevaluate serum potassium frequently after treatment to document response and identify recurrence after redistribution therapy. Continue cardiac monitoring until the acute electrical risk has resolved and a durable potassium-elimination strategy is in place. [8][12]",
        "After IV insulin, use serial glucose testing because hypoglycemia can occur despite dextrose coadministration and may be delayed in ESRD or reduced kidney function. In ESRD, monitor for at least 3 hours after insulin treatment. [13][14]",
        "Before disposition, establish why potassium rose and whether potassium can be eliminated without dialysis. Patients with persistent severe elevation, ECG abnormalities, inadequate renal clearance, or need for urgent dialysis require continued monitored care rather than discharge after a transient laboratory improvement. [7][8][11][12]"
      ],
      "bullets": [
        "Repeat potassium after temporizing treatment and after definitive removal to detect rebound. [8][12][14]",
        "Reassess acid-base status when bicarbonate was used; its acute role is linked to concomitant metabolic acidosis. [11][18]",
        "Reconcile potassium-raising medications and plan follow-up for reintroduction of indicated renin-angiotensin system inhibition after the emergency resolves. [5][9]"
      ],
      "subsections": [],
      "table": {
        "caption": "Post-treatment monitoring targets for emergency hyperkalemia. [8][12][13][14]",
        "columns": [
          "Parameter",
          "Monitoring action",
          "Action if abnormal"
        ],
        "rows": [
          [
            "ECG and rhythm",
            "Continue cardiac monitoring after potassium greater than 6.0 mmol/L or ECG toxicity. [6][8]",
            "Recurrent conduction abnormality or dysrhythmia requires repeat immediate stabilization and escalation of potassium removal. [8][12]"
          ],
          [
            "Serum potassium",
            "Recheck frequently after treatment. [8]",
            "Persistent or recurrent elevation requires reassessment of ongoing source and definitive removal, including hemodialysis when indicated. [11][12]"
          ],
          [
            "Blood glucose",
            "Obtain serial measurements after IV insulin; monitor at least 3 hours in ESRD. [13][14]",
            "Treat hypoglycemia promptly and continue surveillance because impaired kidney function increases risk. [13][14]"
          ]
        ]
      }
    }
  ],
  "faq": [
    {
      "question": "Should a normal ECG delay emergency treatment of severe hyperkalemia?",
      "answer": "No. ECG abnormalities are an important marker of electrical toxicity, but hyperkalemia can progress to ventricular fibrillation without sequential classic ECG changes. In a patient with potassium greater than 6.0 mmol/L and concerning clinical context, use monitoring, repeat biochemical testing when appropriate, and do not delay treatment for confirmation if instability or ECG toxicity is present. [7][8]"
    },
    {
      "question": "Is sodium bicarbonate routine treatment for acute hyperkalemia?",
      "answer": "No. Reserve IV bicarbonate for coexisting metabolic acidosis after immediate membrane stabilization and potassium-shift therapy; without acidosis, bicarbonate lowers potassium only slightly. The KDIGO algorithm lists 50 mmol IV over 15 minutes. [11][12][18]"
    }
  ],
  "references": [
    {
      "number": 1,
      "title": "Hyperkalemia in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/3000318",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com"
    },
    {
      "number": 2,
      "title": "Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S104366181630723X",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 3,
      "title": "An Evidence-Based Narrative Review of the Emergency Department Management of Acute Hyperkalemia - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0736467920313299",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 4,
      "title": "Hyperkalemia management in the emergency department: An expert panel consensus",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S2688115224009871",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 5,
      "title": "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0085253820312709",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 6,
      "title": "Acute hyperkalemia in the emergency department - Ovid",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/euro-emergencymed/fulltext/2020/10000/acute_hyperkalemia_in_the_emergency_department__a.10.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 7,
      "title": "Recent Advances in Nephrology: The Research Gaps... : Nigerian Journal of Clinical Practice",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/njcp/_layouts/15/oaks.journals/downloadpdf.aspx?an=01253091-202502000-00001",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 8,
      "title": "Acute hyperkalemia in adults : Turkish Journal of Emergency Medicine",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/tjem/_layouts/15/oaks.journals/downloadpdf.aspx?an=01949575-202323020-00002",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 9,
      "title": "EMCREG-International Multidisciplinary Consensus... : Cardiorenal Medicine",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/01642367-202515010-00011",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 10,
      "title": "[PDF] Kidney News - May 2010 - American Society of Nephrology",
      "detail": "www.asn-online.org",
      "url": "https://www.asn-online.org/publications/kidneynews/archives/2010/KN_2010_05_may.pdf",
      "authors": "www.asn-online.org",
      "host": "www.asn-online.org"
    },
    {
      "number": 11,
      "title": "Hyperkalemia management in the emergency department - PMC - NIH",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8485984",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 12,
      "title": "Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7448835",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 13,
      "title": "Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4377748",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 14,
      "title": "Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11396335",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 15,
      "title": "Third in a series on hyperkalemia: current views on the treatment of hyperkalemia",
      "detail": "www.escardio.org",
      "url": "https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-14/fourteen-thirteen",
      "authors": "www.escardio.org",
      "host": "www.escardio.org"
    },
    {
      "number": 16,
      "title": "[PDF] Summary form National Institute for Health and Care Excellence ...",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ta623/documents/draft-scope-and-provisional-matrix-comments-table-post-referral",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk"
    },
    {
      "number": 17,
      "title": "Hyperkalaemia | Treatment summaries - BNF - NICE",
      "detail": "bnf.nice.org.uk",
      "url": "https://bnf.nice.org.uk/treatment-summaries/hyperkalaemia",
      "authors": "bnf.nice.org.uk",
      "host": "bnf.nice.org.uk"
    },
    {
      "number": 18,
      "title": "Diagnosis and treatment of hyperkalemia",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/content/84/12/934",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org"
    },
    {
      "number": 19,
      "title": "[PDF] ACE inhibitors and ARBs: Managing potassium and renal function",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/sites/default/files/additional-assets/PDFs/Current_Drug_Therapy_Example.pdf",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org"
    },
    {
      "number": 20,
      "title": "Treatment of hyperkalemia: something old, something new",
      "detail": "www.kidney-international.org",
      "url": "https://www.kidney-international.org/article/S0085-2538(15)00123-4/fulltext",
      "authors": "www.kidney-international.org",
      "host": "www.kidney-international.org"
    },
    {
      "number": 21,
      "title": "A phase 2 study on the treatment of hyperkalemia in patients with ...",
      "detail": "www.kidney-international.org",
      "url": "https://www.kidney-international.org/article/S2157-1716(15)32161-4/pdf",
      "authors": "www.kidney-international.org",
      "host": "www.kidney-international.org"
    },
    {
      "number": 22,
      "title": "Clinical Management of Hyperkalemia - ScienceDirect.com",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0025619620306182",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 23,
      "title": "Review Treatment of hyperkalemia: something old, something new",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0085253815001234",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 24,
      "title": "Sodium bicarbonate administration and subsequent potassium concentration in hyperkalemia treatment",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0735675721005982",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "Hyperkalemia in adults - Symptoms, diagnosis and treatment | BMJ Best Practice US",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/3000318",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com",
      "snippet": "Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.Full textAbstract\n\nClase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclus",
      "score": 0.6768127
    },
    {
      "number": 2,
      "title": "Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S104366181630723X",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease (CKD), diabetes mellitus, or heart failure , . The reported incidence of hyperkalemia varies (<1 to 10 per 100 hospitalizations) ,  depending on the patient cohort and comorbidities. Hyperkalemia can",
      "score": 0.67140645
    },
    {
      "number": 3,
      "title": "An Evidence-Based Narrative Review of the Emergency Department Management of Acute Hyperkalemia - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0736467920313299",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Elsevier logo\n\n## Article preview\n\nElsevier\n\n## The Journal of Emergency Medicine\n\nThe Journal of Emergency Medicine\n\n# Clinical Review An Evidence-Based Narrative Review of the Emergency Department Management of Acute Hyperkalemia\n\n## Abstract\n\n### Background\n\n### Objective\n\n### Methods\n\n### Discus",
      "score": 0.6601948
    },
    {
      "number": 4,
      "title": "Hyperkalemia management in the emergency department: An expert panel consensus",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S2688115224009871",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "consecutive adult ED patients presenting simultaneously with severe bradycardia and severe hyperkalemia. Patients with prehospital cardiac arrest, hemolyzed potassium specimens, or only point-of-care lab results were excluded. Detailed information, including chronic medications, electrocardiogram (E",
      "score": 0.6213807
    },
    {
      "number": 5,
      "title": "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0085253820312709",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "2024, Kidney International Citation Excerpt : \nPractice Point 3.6.6: Consider starting people with CKD with normal to mildly increased albuminuria (A1) on RASi (ACEi or ARB) for specific indications (e.g., to treat hypertension or heart failure with low ejection fraction). The role of RASi (specific",
      "score": 0.6102915
    },
    {
      "number": 6,
      "title": "Acute hyperkalemia in the emergency department - Ovid",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/euro-emergencymed/fulltext/2020/10000/acute_hyperkalemia_in_the_emergency_department__a.10.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "KDIGO potassium Controversies Conference recommended cardiac monitoring and 12-lead ECG for potassium concentrations >6.0 mmol/l.",
      "score": 0.47124818
    },
    {
      "number": 7,
      "title": "Recent Advances in Nephrology: The Research Gaps... : Nigerian Journal of Clinical Practice",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/njcp/_layouts/15/oaks.journals/downloadpdf.aspx?an=01253091-202502000-00001",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "The report proposes that outpatients with acute hyperkalemia, presenting with a potassium level of >6.0 mmol/L or hyperkalemia accompanied by any ECG changes, should be referred to a cardiac monitoring unit in an emergency setting that can promptly address the issue. This suggestion is based on clin",
      "score": 0.6455898
    },
    {
      "number": 8,
      "title": "Acute hyperkalemia in adults : Turkish Journal of Emergency Medicine",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/tjem/_layouts/15/oaks.journals/downloadpdf.aspx?an=01949575-202323020-00002",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Acute hyperkalemia is a widespread problem in the ED with potentially fatal consequences. All patients with K+>6 mmol/l should have an ECG and their vital signs should be monitored. Patients at risk should be identified quickly and rapid laboratory tests should be performed and confirmed using bioch",
      "score": 0.62633044
    },
    {
      "number": 9,
      "title": "EMCREG-International Multidisciplinary Consensus... : Cardiorenal Medicine",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/01642367-202515010-00011",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure (HF), particula",
      "score": 0.278071
    },
    {
      "number": 10,
      "title": "[PDF] Kidney News - May 2010 - American Society of Nephrology",
      "detail": "www.asn-online.org",
      "url": "https://www.asn-online.org/publications/kidneynews/archives/2010/KN_2010_05_may.pdf",
      "authors": "www.asn-online.org",
      "host": "www.asn-online.org",
      "snippet": "Emmett noted that there are other good options for the acute treatment of hyper-kalemia, including intravenous insulin and glucose, inhaled beta-2 agonists, and even sodium bicarbonate—“which may or may not be very effective but is probably safe,” according to Emmett. “Diuretics are also useful, if ",
      "score": 0.38297242
    },
    {
      "number": 11,
      "title": "Hyperkalemia management in the emergency department - PMC - NIH",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8485984",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "Step 3: Treatment options are based on K levels and categorized into _redistribution_ and _elimination_. Hemodialysis is the most effective way to eliminate K; however, it may not always be indicated or readily available. While waiting on a definitive treatment plan for HK management or arranging fo",
      "score": 0.75181264
    },
    {
      "number": 12,
      "title": "Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7448835",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "Treatment algorithm for management of acute hyperkalemia in the emergency department. The thresholds for actions are opinion based. Suggested drug doses are based on a 2010 systematic review  and a subsequent observational study . ECG changes commonly reported with increasing potassium concentration",
      "score": 0.74785584
    },
    {
      "number": 13,
      "title": "Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4377748",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "##  due to decreased renal excretion of potassium. Elevated extracellular potassium can cause cardiac conduction abnormalities including ventricular fibrillation and asystole . The urgent treatment of hyperkalemia is used when patients have electrocardiogram abnormalities associated with hyperkalemi",
      "score": 0.7413937
    },
    {
      "number": 14,
      "title": "Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11396335",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "Clinical guidelines recommend treatment for hyperkalemia should include the administration of intravenous (IV) insulin in doses ranging from 5 to 10 units, along with 25 to 50 g of dextrose [9][10]. Insulin reduces serum potassium levels by shifting it into the cells—this promptly restores the electr",
      "score": 0.6964752
    },
    {
      "number": 15,
      "title": "Third in a series on hyperkalemia: current views on the treatment of hyperkalemia",
      "detail": "www.escardio.org",
      "url": "https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-14/fourteen-thirteen",
      "authors": "www.escardio.org",
      "host": "www.escardio.org",
      "snippet": "Virtually every patient with hyperkalemia presents at the ED in an acutely ill condition. During the process of diagnosing the case, the moment it become obvious that the sole reason for the acute condition lies with hyperkalemia along with other comorbidities all measures should be taken to bring t",
      "score": 0.62742686
    },
    {
      "number": 16,
      "title": "[PDF] Summary form National Institute for Health and Care Excellence ...",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ta623/documents/draft-scope-and-provisional-matrix-comments-table-post-referral",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk",
      "snippet": "sodium zirconium cyclosilicate. h) In your response to the question about the relevant comparators, please could you let us know if sodium zirconium cyclosilicate should be included as a comparator? We do not consider sodium zirconium cyclosilicate as a comparator as it is not presently licensed and",
      "score": 0.70702106
    },
    {
      "number": 17,
      "title": "Hyperkalaemia | Treatment summaries - BNF - NICE",
      "detail": "bnf.nice.org.uk",
      "url": "https://bnf.nice.org.uk/treatment-summaries/hyperkalaemia",
      "authors": "bnf.nice.org.uk",
      "host": "bnf.nice.org.uk",
      "snippet": "High Sodium zirconium cyclosilicate or patiromer calcium are recommended in the emergency management of severe hyperkalaemia to remove potassium from the body.",
      "score": 0.6999322
    },
    {
      "number": 18,
      "title": "Diagnosis and treatment of hyperkalemia",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/content/84/12/934",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org",
      "snippet": "Beta-2 receptor agonists produce a similar effect. The shift of potassium into cells with insulin and beta-2-adrenergic receptor stimulation is brought about by increases in sodium-potassium ATPase pump activity, primarily in skeletal muscle cells.\n\nSodium bicarbonate, in the absence of acidosis, lo",
      "score": 0.6922474
    },
    {
      "number": 19,
      "title": "[PDF] ACE inhibitors and ARBs: Managing potassium and renal function",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/sites/default/files/additional-assets/PDFs/Current_Drug_Therapy_Example.pdf",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org",
      "snippet": "nice.org.uk/Guidance/CG169. Accessed August 12, 2019. 56. Think Kidneys. “Sick day” guidance in patients at risk of acute kidney injury: a position statement from the Think Kidneys Board.  sites/2/2018/01/Think-Kidneys-Sick-Day-Guidance-2018.pdf. Accessed August 12, 2019. 57. Meaney CJ, Beccari MV, ",
      "score": 0.65146625
    },
    {
      "number": 20,
      "title": "Treatment of hyperkalemia: something old, something new",
      "detail": "www.kidney-international.org",
      "url": "https://www.kidney-international.org/article/S0085-2538(15)00123-4/fulltext",
      "authors": "www.kidney-international.org",
      "host": "www.kidney-international.org",
      "snippet": "Insulin, beta-2 agonists, and bicarbonate accelerate the movement of potassium into muscle cells, and these agents are widely used to treat “severe”",
      "score": 0.41534993
    },
    {
      "number": 21,
      "title": "A phase 2 study on the treatment of hyperkalemia in patients with ...",
      "detail": "www.kidney-international.org",
      "url": "https://www.kidney-international.org/article/S2157-1716(15)32161-4/pdf",
      "authors": "www.kidney-international.org",
      "host": "www.kidney-international.org",
      "snippet": "Hyperkalemia contributes to significant mortality and limits the use of cardioprotective and renoprotective.",
      "score": 0.3656837
    },
    {
      "number": 22,
      "title": "Clinical Management of Hyperkalemia - ScienceDirect.com",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0025619620306182",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences. Despite various guidelines, no universally accepted consensus exists on best practices for hyperkalemia monitoring, with variations in precise potassium (K+) concentration thresholds or for the management of a",
      "score": 0.58777803
    },
    {
      "number": 23,
      "title": "Review Treatment of hyperkalemia: something old, something new",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0085253815001234",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "The most commonly recommended regimen for emergency treatment of severe hyperkalemia is a bolus intravenous injection of 10 U of regular insulin, which, if",
      "score": 0.5408517
    },
    {
      "number": 24,
      "title": "Sodium bicarbonate administration and subsequent potassium concentration in hyperkalemia treatment",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0735675721005982",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "### J Emerg Med (2018) \n   P. Rossignol _et al._\n### Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future\n\n### Pharmacol Res (2016) \n   A.V. Alfonzo _et al._\n### Potassium disorders—clinical spectrum and emergency management\n\n### Resuscitation (20",
      "score": 0.53181785
    }
  ],
  "publishedAt": "2026-09-15T21:46:42.940213+00:00",
  "updatedAt": "2026-09-15T21:46:42.940213+00:00",
  "readingMinutes": 5,
  "slug": "hyperkalemia-emergency-treatment"
}